Neem (Azadirachta indica)
What Is Neem?
Neem is catalogued in the Materia Medica under the binomial Azadirachta indica, a plant of the Meliaceae family, native to the Indian subcontinent. The material in circulation is leaf, bark, seed oil — bark, stripped from stem or trunk. Most people search for it simply as Neem; suppliers, pharmacopoeias and interaction databases list it as Azadirachta indica, and matching the two is the first step in identifying what is actually in a product. In the hand it reads as very bitter, garlic-like, pungent — a practical marker of freshness and correct identification.
The written history of Neem begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the leaf, bark, seed oil contains. Beyond its practical use it carries cultural associations — called 'Village Pharmacy' in India — revered for 5,000 years and associated with the goddess Sitala (smallpox deity).
Today most searches for Neem come from people reading about psoriasis, antibacterial, antifungal and liver support, or checking how it sits alongside a medication they already take. The use most often documented in the literature is antimicrobial — broad-spectrum antibacterial and antifungal, followed by antiparasitic (azadirachtin — used as biopesticide).
How Does Neem Work?
Neem works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in leaf, bark, seed oil rather than by one marker molecule.
The older understanding of Neem is procedural rather than molecular — which part to take, in what season, and in what medium — and modern constituent work has largely been an attempt to explain why those procedures were chosen.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 3 sources. Reported findings centre on neem stick toothbrushing and neem mouthwash reduce plaque and gingivitis in multiple small RCTs. Where research exists, it examines antimicrobial — broad-spectrum antibacterial and antifungal, antiparasitic (azadirachtin — used as biopesticide) and anti-inflammatory and hepatoprotective. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into fixed oil and glycerin — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
What makes Neem distinct is the combination rather than any one molecule: the same compound classes appear in other botanicals, but their ratio here — and the leaf, bark, seed oil they are drawn from — is what the traditional and research literature both describe.
Because these constituents are processed by the same pathways that handle many medicines, Neem is documented as interacting with diabetes medications, immunosuppressants and hepatotoxic drugs. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Neem can differ substantially; this is why reference entries specify leaf, bark, seed oil and, where they exist, standardisation markers.